Guardion Health Sciences, Inc. (GHSI) financial statements (2022 and earlier)

Company profile

Business Address 2925 RICHMOND AVENUE
HOUSTON, TX 77098
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9,09010,55912,50343,3308,5199,79511,603
Cash and cash equivalents4,0943,5645,50243,3308,5199,79511,603
Short-term investments4,9966,9957,000    
Receivables1,4122,2691,88565112334
Inventory, net of allowances, customer advances and progress billings3687939562893851,2841,235
Inventory3687939562893851,2841,235
Prepaid expense 1,2471,203313180232274
Other current assets     254333
Other undisclosed current assets1,200    (254)(308)
Total current assets:12,06914,86716,54743,9969,09511,33413,171
Noncurrent Assets
Operating lease, right-of-use asset2429339379419458496
Property, plant and equipment111269246266286306305
Intangible assets, net (including goodwill)11,25623,44623,83950505050
Goodwill 11,89311,988    
Intangible assets, net (excluding goodwill)11,25611,55311,85150505050
Prepaid expense  302    
Deposits noncurrent assets 11212121212
Other noncurrent assets    121212
Other undisclosed noncurrent assets    (12)(12)(12)
Total noncurrent assets:11,39123,74724,738707766825863
TOTAL ASSETS:23,46138,61341,28544,7029,86112,15914,034
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,1371,6561,636749736759495
Accounts payable2411,183768230608577333
Accrued liabilities895473868519128183162
Derivative instruments and hedges, liabilities    26819
Due to related parties   135298230311
Other undisclosed current liabilities223141699814160157
Total current liabilities:1,1591,9701,8059831,0741,157983
Noncurrent Liabilities
Long-term debt and lease obligation4 186229272314355
Operating lease, liability4 186229272314355
Other undisclosed noncurrent liabilities(4) (186)(229) (314)(355)
Total noncurrent liabilities:  186229272314355
Total liabilities:1,1631,9701,9911,2121,3461,4711,338
Stockholders' equity
Stockholders' equity attributable to parent22,29836,64339,29343,4908,51510,68812,696
Common stock24242424158888
Additional paid in capital101,075100,900100,536100,19362,58361,30961,173
Accumulated deficit(78,802)(64,282)(61,267)(56,727)(54,083)(50,709)(48,566)
Total stockholders' equity:22,29836,64339,29343,4908,51510,68812,696
TOTAL LIABILITIES AND EQUITY:23,46138,61341,28544,7029,86112,15914,034

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues2,6273,1491,2242332002531,191
Cost of revenue
(Cost of Goods and Services Sold)
(1,564)(1,761)(665)(133)(1,079)(114)(645)
Gross profit:1,0641,388559100(879)139546
Operating expenses(15,585)(4,404)(5,099)(2,770)(2,477)(2,291)(1,255)
Other undisclosed operating income 0     
Operating loss:(14,521)(3,016)(4,541)(2,670)(3,356)(2,152)(708)
Nonoperating income (expense)110 (21)8(1)
Interest and debt expense    (0)(4)(2)
Other undisclosed income from continuing operations before equity method investments, income taxes0      
Net loss:(14,520)(3,015)(4,540)(2,670)(3,377)(2,147)(711)
Other undisclosed net income (loss) attributable to parent(0)   344
Net loss available to common stockholders, diluted:(14,520)(3,015)(4,540)(2,670)(3,374)(2,143)(707)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(14,520)(3,015)(4,540)(2,670)(3,377)(2,147)(711)
Comprehensive loss, net of tax, attributable to parent:(14,520)(3,015)(4,540)(2,670)(3,377)(2,147)(711)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: